REF impact weighting should be 25 per cent, says Witty

By Elizabeth Gibney. Impact should be given a weighting of 25 per cent at the next research excellence framework, the author of a government-commissioned review has said.
Sir Andrew Witty, chief executive of GlaxoSmithKline, said the introduction of impact in the forthcoming REF provided “a different sort of incentive to translate research insights into benefits for local businesses”. Read more...